Laxmi Organic Industries Limited – Investor Presentation Summary

Key Operational Highlights

  • Delivered strong double-digit volume growth across the portfolio.
  • Commissioned new Diketene capacity at Dahej site.
  • Stabilized Ethyl Acetate (ETAC) capacity at Lote site.
  • Managed supply chain disruptions effectively to ensure timely material availability.
  • Key drivers: Higher realizations, cost pass-through mechanisms, and operating leverage from new capacities.

Segment-wise Performance

  • Specialties: Delivered positive volumes and strong double-digit revenue and reported margin growths. Feedstock price increases could not be immediately passed on to contract customers. Ramp-up of Dahej will lead to operating leverage.
  • Essentials: Delivered strong double-digit volume, revenue and margin growths driven by commissioning of ETAC Capacity at Lote and better price realizations due to timely pass-through of cost inflation.

Financial Highlights

  • Revenue: Rs. 10,827 Mn (Q2 FY27), Rs. 20,511 Mn (H1 FY27)
  • EBITDA: Rs. 1,080 Mn (Q2 FY27), Rs. 2,223 Mn (H1 FY27)
  • PAT: Rs. 570 Mn (Q2 FY27), Rs. 1,247 Mn (H1 FY27)
  • EBITDA Margin: 10.0% (Q2 FY27), 10.8% (H1 FY27)
  • Gross Margin: 33.6% (Q2 FY27), 35.4% (H1 FY27)
  • YoY comparison: Revenue growth of 54.7% (Q2), 47.3% (H1); EBITDA growth of 191.3% (Q2), 227.8% (H1); PAT growth of 417.6% (Q2), 284.9% (H1)
  • QoQ comparison: Revenue growth of 11.8% (Q2 vs Q1); EBITDA decline of 5.5% (Q2 vs Q1); PAT decline of 15.8% (Q2 vs Q1)
  • Drivers of financial performance: Higher realizations, cost pass-through, and operating leverage aided strong margin growth despite higher energy and freight costs
  • Note: Q2FY26 and H1FY26 EBITDA includes one-time supply chain redesign project expense INR 23 Mn (PAT INR 17 Mn) and INR 102 Mn (PAT 76 Mn) respectively

Geographical Revenue Split

Not Specified

Balance Sheet Snapshot

Not Specified

Capex & Cash Flow Health

  • Capital Expenditure: New capacities commissioned at Dahej (Diketene) and Lote (Ethyl Acetate)
  • Free Cash Flow: Not Specified
  • Operating Cash Flow: Not Specified
  • Net Debt Movement: Not Specified
  • Investment Rationale: Capacity expansion and operational leverage

Strategic & R&D Initiatives

  • Commissioned new Diketene capacity at Dahej
  • Stabilized Ethyl Acetate capacity at Lote
  • Expected impact: Ramp-up of Dahej will lead to operating leverage benefits
  • Strategic Rationale: Expanding production capabilities and market position

Industry Trends & Business Environment

  • Markets remained volatile due to geopolitical disturbances
  • Impact on feedstock prices and supply chain
  • Company managed supply chain disruptions well to ensure timely material availability

Management Commentary & Growth Outlook

  • Markets remained volatile due to geopolitical disturbances, impacting feedstock prices and supply chain
  • Strong double-digit volume and revenue growth across the portfolio
  • Supply chain disruptions managed well to ensure timely material availability
  • Higher realizations, cost pass-through and operating leverage aided strong margin growth despite higher energy and freight costs
  • Ethyl Acetate capacity at Lote stabilized; new Diketene capacity at Dahej commissioned
  • No specific FY guidance or market share targets provided

ESG Updates

  • Laxmi Lote Site received National Level Recognition - "HSE Team of the Year Award 2026"
  • Successful Recertification of ISCC Plus GHG Certification for Dahej (completed Nov 17-19, 2025 without any non-conformity)
  • ISCC PLUS is a globally recognized, voluntary certification system for bio-based, renewable, and circular raw materials